Welcome to the N.O.S. website!

GRASSROOTS ADVOCACY AT WORK!

Thank you to everyone who contacted your state senators regarding LB 882 known as the "chemo parity bill". This legislation passed and was signed by Governor Heineman on 4/6/2012!

 Register today for the next NOS meeting on May 10th!

---------------------------------------

Registration also open now for the 13th Annual ASCO Review

**June 16th, 2012 (click link above to register)

 

-----------------------------

 

Thank you to everyone who attended the recent GU/Prostate Oncology Update! Thank you to our great speakers and also to our  vendors for supporting the event!

-----------------------------------------------------

 


WELCOME NEW CORPORATE MEMBERS!

NOS is pleased to welcome TEVA and SEATTLE GENETICS to the NOS! Please thank all of our corporate member representatives when you see them! We look forward to working with you this year! For more information & to see a complete list of NOS Corporate Members please visit the Corporate Membership page (see tab on the left)


New Drug Developments
Corporate Member Genentech released New Drug: 
 
ERIVEDGE (vismodegib) capsule for metastatic basal cell cancer (2/2012).

Corporate Member Pfizer released new drug: INLYTA (Axitinib) for advanced renal cell cancer after progression on one systemic treatment (1/2012).

 

 

 

 

 

 

 

 


Upcoming events

16 Jun 2012 7:00 AM • Omaha Marriott, Regency

________________

--------------------------------------

Please visit the "Events" page for more details and information on future NOS events...


 
 

Thank you to our Corporate Members!

Nebraska Oncology Society
Midwest Cancer Center
7500 Mercy Road
Omaha, NE 68124
Telephone (402) 593-3141
Fax (402) 593-3145

nmandolfo@nebraskacancer.com

 


Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds